Using Ivabradine to Treat Long-Haul COVID and POTS Symptoms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify the prevalence of postural orthostatic tachycardia syndrome (POTS) among individuals with long-haul COVID symptoms and evaluate the effectiveness of ivabradine in treating these symptoms. Participants will be assessed for POTS and randomized to receive either ivabradine or a placebo to determine its impact on heart rate and overall quality of life. Additionally, the study will explore the underlying immunoinflammatory and genomic factors associated with long-haul COVID and POTS. The research will also utilize wearable technology to enhance diagnostic accuracy for POTS.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age 18-80
2. History of documented COVID-19 infection of any severity to include a positive COVID-19 PCR, or antibody test
3. Meets criteria for 'long-haul' COVID-19 with symptoms \>12 weeks following acute illness
4. Able and willing to provide informed consent and participate for study duration
5. Willing to participate in the nested randomized controlled trial of ivabradine if RCT enrollment criteria are met
6. Access to a primary healthcare provider and proof of health insurance

Inclusion Criteria for non-LHC Cohort

1. Age 18-80
2. History of documented COVID-19 infection of any severity to include a positive COVID-19 PCR, or antibody test
3. Does not meet criteria for 'long-haul' COVID-19
4. Able and willing to provide informed consent and participate for study duration
5. Willing to participate in the nested randomized controlled trial of ivabradine if RCT enrollment criteria are met
6. Access to a primary healthcare provider and proof of health insurance

Inclusion Criteria for POTS RCT:

1. Age 18-80; Meets criteria for 'long-haul' COVID-19

   1. Documented history of COVID-19 infection made available to study team 1914
   2. Lack of documented history, but evidence of infection from sensitive antibody tests
2. Able and willing to provide informed consent and participate for study duration
3. Volunteers with or without LHC combined with POTS based on an increase in comparing the supine heart rate to standing heart rate \>20 beats per minute with a drop in systolic blood pressure less than 20 mm Hg or a drop in diastolic blood pressure less than 10 mm Hg will be included, OR additionally, volunteers with or without LHC and a 24-hour mean heart rate of 90 beats per minute or more (in sinus rhythm) will be diagnosed with IST and be included.
4. For females of childbearing age - willing to use a highly effective form of contraceptive with \<1% failure rate or practice abstinence for the duration of the study

Exclusion Criteria:

1. Resting heart rate \<60 bpm
2. Atrial fibrillation
3. Supraventricular tachycardia
4. Allergic reaction or known contraindications to study drug

   1. Acute decompensated heart failure
   2. Clinically significant hypotension, defined as a drop in systolic BP \>20 mmHg or drop in diastolic \>10 mmHg during orthostatic vital signs testing.
   3. Sick sinus syndrome, sinoatrial block or 3rd degree AV block, unless a functioning demand pacemaker is present
   4. Clinically significant bradycardia
   5. Severe hepatic impairment
   6. Pacemaker dependence (heart rate maintained exclusively by the pacemaker)
   7. Concomitant use of cytochrome P450 3A4 (CYP3A4) inhibitors or inducers
5. Pregnant/lactating females
6. Impaired gastrointestinal absorption that would preclude oral drug administration
7. Taking any of the following without discontinuation in consultation with the volunteer's healthcare provider and a one-week washout period:

   1. ivabradine
   2. beta-blockers
   3. calcium- channel blockers
   4. cholinesterase inhibitors (pyridostigmine),
   5. vasoconstrictors (midodrine, octreotide, droxidopa, stimulants)
   6. sympatholytics (clonidine, methyldopa)
   7. blood volume enhancers (fludrocortisone, desmopressin, salt supplementation)
   8. oral ketoconazole (contraindicated)
8. Acute suicidality identified at screening

   -

Where it's running

• Uniformed Services University
  Bethesda, Maryland, United States Recruiting

Study contacts

• Principal investigator: David L Saunders, MD, MPH — Uniformed Services University of the Health Sciences
• Study coordinator: Roshila Mohammed, MBBS
• Email: clinical.research.unit.53-ggg@usuhs.edu
• Phone: (301) 318-6024

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Deep phenotyping of Postural Orthostatic Tachycardia Syndrome

  This study is trying to better understand Postural Orthostatic Tachycardia Syndrome (POTS) by looking at different tests and samples from patients to improve diagnosis and treatment options.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT06292104

• High salt diet for treating Postural Orthostatic Tachycardia Syndrome

  This study tests if a high salt diet can help people with Postural Orthostatic Tachycardia Syndrome feel better by improving their symptoms and blood volume.

  Recruiting University of Calgary · Calgary, Alberta · NCT05924646

• Testing IV saline for cognitive function in POTS and Long COVID patients

  This study is testing whether IV saline can help improve brain fog and mental fatigue in people with POTS and Long COVID.

  Recruiting University of Calgary · Calgary, Alberta · NCT05914649

• A study using wearable devices to manage Long COVID symptoms

  This study is testing if using wearable devices can help people with Long COVID manage their symptoms and improve their quality of life.

  Recruiting Scripps Translational Science Institute · La Jolla, California · NCT05741112

• Improving blood pressure control in children who faint

  This study is testing if certain movements can help children aged 6-18 who faint feel better by improving their blood pressure and heart function compared to regular advice.

  Recruiting Simon Fraser University · Burnaby, British Columbia · NCT05633693

• Assessing counterpressure maneuvers for preventing fainting in children

  This study is testing if teaching children techniques to prevent fainting can help them avoid losing consciousness when they visit the emergency room.

  Recruiting Simon Fraser University · Vancouver, British Columbia · NCT05555771

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.